Medication dependence and anxiety

por von Moltke, Lisa L., Greenblatt, David J.
Publicado 2003

Physiologically‐Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan

por Sun, Lei, von Moltke, Lisa, Rowland Yeo, Karen
Publicado 2020

Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination

por Sun, Lei, von Moltke, Lisa, Rowland Yeo, Karen
Publicado 2020

Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet

por Sun, Lei, Yagoda, Sergey, Du, Yangchun, von Moltke, Lisa
Publicado 2019

Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age

por Kumar, Vipul, Lu, Hong, Hard, Marjie, von Moltke, Lisa
Publicado 2019

Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine‐Alone Tablets: Results From a Randomized, Crossover Rela...

por Sun, Lei, McDonnell, David, Liu, Jianjun, von Moltke, Lisa
Publicado 2018

Using physiologically‐based pharmacokinetic modeling for predicting the effects of hepatic impairment on the pharmacokinetics of olanzapine and samidorphan given as a combination t...

por Sun, Lei, Barter, Zoe, von Moltke, Lisa, Rowland Yeo, Karen
Publicado 2021

Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate

por Sun, Lei, Yagoda, Sergey, Yao, Baiyun, Graham, Christine, von Moltke, Lisa
Publicado 2019

Cognitive toxicity of drugs used in the elderly

por von Moltke, Lisa L., Greenblatt, David J., Romach, Myroslava K., Sellers, Edward M.
Publicado 2001

Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil

por Hard, Marjie L., Wehr, Angela Y., Sadler, Brian M., Mills, Richard J., von Moltke, Lisa
Publicado 2018

Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia

por Hard, Marjie L., Wehr, Angela Y., Du, Yangchun, Weiden, Peter J., Walling, David, von Moltke, Lisa
Publicado 2018

Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal(®) Dispersion used for initiation of the long-acting antipsychotic aripiprazole lau...

por Hard, Marjie L., Wehr, Angela, von Moltke, Lisa, Du, Yangchun, Farwick, Sarah, Walling, David P., Sonnenberg, John
Publicado 2019

Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Stud...

por Weiden, Peter J., Du, Yangchun, von Moltke, Lisa, Wehr, Angela, Hard, Marjie, Marandi, Morteza, Walling, David P.
Publicado 2020

Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model

por Hard, Marjie L., Mills, Richard J., Sadler, Brian M., Wehr, Angela Y., Weiden, Peter J., von Moltke, Lisa
Publicado 2017

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

por McConnell, Scott A, Desai, Dharmik N, Faldu, Sejal P, Hard, Marjie L, Wehr, Angela Y, Weiden, Peter J, von Moltke, Lisa
Publicado 2017

658. Diagnostic Testing Among Patients with Suspected Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III a Phase 3 Clinical Trial: Implications for Clinical Practic...

por Sims, Matthew, Khanna, Sahil, Pardi, Darrell, Feuerstadt, Paul, Berenson, Charles, Wu, Henry, Wang, Elaine E, Wang, Elaine E, McGovern, Barbara, von Moltke, Lisa
Publicado 2021

Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection

por Cohen, Stuart, Louie, Thomas, Berenson, Charles, Amin, Alpesh, Lombardi, David, Pham, Sissi, Huang, Shirley, Wang, Elaine, Hasson, Brooke, McGovern, Barbara, Von Moltke, Lisa
Publicado 2022

19. The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (r...

por Hohmann, Elizabeth, Feuerstadt, Paul, Oneto, Caterina, Berenson, Charles, Lee, Christine, Pham, Sissi, Zhu, Lei, Reese, Pat Ray, Wu, Henry, Wang, Elaine E, Wang, Elaine E, von Moltke, Lisa, Garey, Kevin W
Publicado 2021

Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers

por Dijkstra, Francis M., Zuiker, Rob G. J. A., Siebenga, Pieter S., Leigh‐Pemberton, Richard A., Sun, Lei, Manthis, Joan D., de Kam, Marieke L., Lin, Richard, von Moltke, Lisa L., Rezendes, David, van Gerven, Joop M. A.
Publicado 2022

Efficacy and Safety of Investigational Microbiome Drug SER-109 for Treatment of Recurrent Clostridioides difficile Infection

por McGovern, Barbara, Sims, Mathew, Kraft, Colleen, Wang, Elaine, Brady, Kelly, Ford, Christopher, Edward, O’Brien, Lombardo, Mary-Jane, Wortman, Jennifer, Litcofsky, Kevin, Mahoney, Jennifer, McChalicher, Christopher, Winkler, Jonathan, Garant, Sarah, Aunins, John, Henn, Matthew, von Moltke, Lisa
Publicado 2021